NCT03162367View on ClinicalTrials.gov

Efficacy Of Autologous Epidermal Cell Suspension And Silver Sulfadiazine Ointment In Burn

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 10, 2019

Primary Completion Date

March 15, 2020

Study Completion Date

March 15, 2020

Conditions
Burn
Interventions
BIOLOGICAL

Autologous epidermal cell suspension

First skin samples taken from normal skin by 4mm punch will be send to laboratory for preparation of epidermal cell suspension and this suspension transfer to one area of second degree burn

DRUG

Silver sulfadiazine ointment

the area with second degree burn dresses by silver sulfadiazine ointment and dressing change each 12 hour till 10 day

Trial Locations (1)

Unknown

Sina hospital, Tabriz

All Listed Sponsors
lead

SCARM Institute, Tabriz, Iran

OTHER_GOV

NCT03162367 - Efficacy Of Autologous Epidermal Cell Suspension And Silver Sulfadiazine Ointment In Burn | Biotech Hunter | Biotech Hunter